文献速递母胎医学产科

游离胎儿DNA筛查与诊断单基因疾病——我们将走向何方?

cfDNA screening and diagnosis of monogenic disorders - where are we heading?
PubMed 文献 · Prenat Diagn · 2018-01-24

本文综述了利用孕妇血浆DNA分析对胎儿单基因疾病进行无创检测的技术进展,重点介绍了基于检测母体血浆中单倍型相关SNP等位基因来确定胎儿遗传自父母哪条单倍型的相对单倍型剂量分析,该方法无需为每个突变定制试剂,可评估复杂突变并具备多重检测能力,使无创产前诊断更具可扩展性,可能推动游离胎儿DNA检测的下一波临床应用。

要点

  • 游离胎儿DNA分析已广泛用于胎儿染色体非整倍体无创产前筛查。
  • 胎儿单基因疾病也可通过孕妇血浆DNA分析实现无创检测。
  • 相对单倍型剂量分析需父母单倍型信息,可直接获取而减少用家系成员DNA推断。

核心结论

  • 游离胎儿DNA检测新技术使胎儿单基因疾病无创产前诊断更具可扩展性,可能推动其下一波临床应用。

研究设计与样本

  • 本文为综述,总结利用孕妇血浆DNA分析无创检测胎儿单基因疾病的技术进展。

主要发现

  • 通过检测母体血浆中单倍型相关SNP等位基因,可确定胎儿继承的父母单倍型,从而评估胎儿突变状态。
  • 相对单倍型剂量分析需要父母单倍型信息来解读母体血浆DNA数据中的胎儿遗传模式。
  • 父母单倍型信息可通过直接方式获得,减少利用其他家系成员DNA推断单倍型的需要。
  • 该技术可评估复杂突变,并具备多重检测能力,可同时评估多个基因和突变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cell-free fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use. Fetal monogenic diseases have also been shown to be amenable to non-invasive detection by maternal plasma DNA analysis. A number of recent technological developments in this area has increased the level of clinical interest, particularly as one approach does not require customized reagents per mutation. The mutational status of the fetus can be assessed by determining which parental haplotype that fetus has inherited based on the detection of haplotype-associated SNP alleles in maternal plasma. Such relative haplotype dosage analysis requires the input of the parental haplotype information for interpretation of the fetal inheritance pattern from the maternal plasma DNA data. The parental haplotype information can be obtained by direct means, reducing the need to infer haplotypes using DNA from other family members. The technique also allows the assessment of complex mutations and has multiplexing capabilities where a number of genes and mutations can be assessed at the same time. These advantages allow non-invasive prenatal diagnosis of fetal monogenic diseases to be much more scalable. These applications may drive the next wave of clinical adoption of cell-free fetal DNA testing. © 2018 The Authors Prenatal Diagnosis Published by John Wiley & Sons Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Chiu EKL, Hui WWI, Chiu RWK, et al. cfDNA screening and diagnosis of monogenic disorders - where are we heading? Prenat Diagn. 2018. PMID: 29314147. doi:10.1002/pd.5207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。